MiR-145, a Microrna Targeting ADAM17, Inhibits the Invasion and Migration of Nasopharyngeal Carcinoma Cells.

Jing Wu,Li Yin,Ning Jiang,Wen-Jie Guo,Jia-Jia Gu,Meng Chen,You-You Xia,Jian-Zhong Wu,Dan Chen,Jian-Feng Wu,De-Jun Wang,Dan Zong,Nan Zhang,Kai Ding,Teng Huang,Xia He

DOI: https://doi.org/10.1016/j.yexcr.2015.08.006

IF: 4.145

2015-01-01

Experimental Cell Research

Abstract:MiR-145 is downregulated and functions as a tumor suppressor in many malignancies. In this study, the biological function, molecular mechanism, and direct target genes of miR-145 in nasopharyngeal carcinoma (NPC) cells were investigated. Cell survival was detected by cell viability assay, and cell cycle was determined through flow cytometry. Invasion and migration of NPC cells were examined using cell invasion and wound healing assays, respectively. A disintegrin and metalloproteinase 17 (ADAM17) was verified as the target of miR-145 through luciferase reporter assay, qRT-PCR, and Western blot analysis. In NPC cell lines, miR-145 expression was significantly downregulated and ADAM17 protein expression was upregulated. ADAM17 was downregulated at the post-transcriptional level by miR-145 via the binding site of ADAM17-3′UTR. Transfection with miR-145 mimic suppressed cell growth and induced cell cycle arrest in the G0/G1 phase by upregulating key G0/G1 phase regulators, namely, p53 and p21. MiR-145 also inhibited cellular migration and invasion through targeting ADAM17 involving the regulation of EGFR and E-cadherin. Knockdown of ADAM17 elicited similar effects to that of miR-145 on NPC cells. This study reveals that miR-145 suppressed the invasion and migration of NPC cells by targeting ADAM17. Thus, miR-145 could be a therapeutic target for NPC.